Drug Profile
Budesonide controlled release - Calliditas Therapeutics
Alternative Names: Kinpeygo; Nefecon; NEFEGAN; PL-56; TARPEYOLatest Information Update: 25 Mar 2024
Price :
$50
*
At a glance
- Originator Uppsala University
- Developer Calliditas Therapeutics; Everest Medicines
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Corticosteroids; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed IgA nephropathy